Replies to post #19297 on Bioelectronics Corp (BIEL)

[fuente]

Can't disagree with the 'shotgun' approach over the years. They should have focused on one market (if at all) back then.

FDA approval would change everything, but you're right in that the way things have been run is very disorganized, as has greatly affected the pps.

[colorofmoney]

"The money they are currently spending on marketing and salaries would be better deployed conducting further studies to more adequately prove that the product is both safe and effective."

FYI - They have already accomplished that.